{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T14:31:38Z","timestamp":1787841098571,"version":"build-2784847793"},"reference-count":39,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,6]],"date-time":"2021-06-06T00:00:00Z","timestamp":1622937600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,10]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>\n                      Priapism is defined as a persistent penile erection lasting more than 4 h. We searched the literature for reviews, case reports, and series for patients with lymphoproliferative disorders who developed priapism. The search involved all the lymphoproliferative disorders included in the revised 2016 World Health Organization classification of lymphoid neoplasms including chronic lymphocytic leukemia, multiple myeloma, Waldenstrom macroglobulinemia, and lymphomas. A total of 16 articles were found. The search included cases up to 4\n                      <jats:sup>th<\/jats:sup>\n                      January 2021. Priapism was seen most commonly as the first manifestation of lymphoproliferative disorders, rarely seen after treatment or after diagnosis.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1016\/j.hemonc.2021.05.003","type":"journal-article","created":{"date-parts":[[2021,6,10]],"date-time":"2021-06-10T04:30:37Z","timestamp":1623299437000},"page":"176-182","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":6,"title":["Priapism in Lymphoproliferative Disorders"],"prefix":"10.4103","volume":"15","author":[{"given":"Elrazi A.","family":"Ali","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sundus","family":"Sardar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed A.","family":"Yassin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-2-20241211","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1182\/blood-2016-01-643569","article-title":"The 2016 revision of the World Health Organization classification of lymphoid neoplasms","volume":"127","author":"Swerdlow","year":"2016","journal-title":"Blood"},{"key":"R2-2-20241211","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1046\/j.1464-410X.2002.03022.x","article-title":"Priapism in sickle-cell disease; incidence, risk factors and complications\u2013an international multicentre study","volume":"90","author":"Adeyoju","year":"2002","journal-title":"BJU Int"},{"key":"R3-2-20241211","first-page":"e14335","article-title":"Thalassemia and priapism: a literature review of a rare association","volume":"13","author":"Sardar","year":"2021","journal-title":"Cureus"},{"key":"R4-2-20241211","first-page":"e2021193","article-title":"Priapism in patients with chronic myeloid leukemia (CML): a systematic review: priapism in chronic myeloid leukemia","volume":"92","author":"Ali","year":"2021","journal-title":"Acta Biomed"},{"key":"R5-2-20241211","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1002\/ccr3.3541","article-title":"Essential thrombocythemia with (type2) calreticulin presented as stuttering priapism case report and review of literature","volume":"9","author":"Ali","year":"2021","journal-title":"Clin Case Rep"},{"key":"R6-2-20241211","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1111\/j.1553-2712.1996.tb03520.x","article-title":"Priapism: etiology and management","volume":"3","author":"Mulhall","year":"1996","journal-title":"Acad Emerg Med"},{"key":"R8-2-20241211","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1016\/j.urology.2015.02.025","article-title":"Priapism impact profile questionnaire: development and initial validation","volume":"85","author":"Burnett","year":"2015","journal-title":"Urology"},{"key":"R9-2-20241211","doi-asserted-by":"crossref","first-page":"21","DOI":"10.4065\/78.1.21","article-title":"Review of 1027 patients with newly diagnosed multiple myeloma","volume":"78","author":"Kyle","year":"2003","journal-title":"Mayo Clin Proc"},{"key":"R10-2-20241211","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1097\/01.ju.0000087608.07371.ca","article-title":"Members of the erectile dysfunction guideline update panel; American Urological Association. American Urological Association guideline on the management of priapism","volume":"170","author":"Montague","year":"2003","journal-title":"J Urol"},{"key":"R11-2-20241211","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/j.urology.2005.11.045","article-title":"Long-term oral phosphodiesterase 5 inhibitor therapy alleviates recurrent priapism","volume":"67","author":"Burnett","year":"2006","journal-title":"Urology"},{"key":"R12-2-20241211","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.2147\/TCRM.S3336","article-title":"Tadalafil in the treatment of erectile dysfunction","volume":"4","author":"Coward","year":"2008","journal-title":"Ther Clin Risk Manag"},{"key":"R13-2-20241211","doi-asserted-by":"crossref","first-page":"2530","DOI":"10.1002\/cncr.25765","article-title":"Racial differences in the presentation and outcomes of diffuse large B-cell lymphoma in the United States","volume":"117","author":"Shenoy","year":"2011","journal-title":"Cancer"},{"key":"R14-2-20241211","doi-asserted-by":"crossref","first-page":"3724","DOI":"10.1182\/blood-2010-05-282632","article-title":"Incidence of hematologic malignancies in Europe by morphologic subtype: results of the HAEMA- CARE project","volume":"116","author":"Sant","year":"2010","journal-title":"Blood"},{"key":"R15-2-20241211","doi-asserted-by":"crossref","first-page":"s177","DOI":"10.1179\/102453312X13336169156933","article-title":"Thrombosis in multiple myeloma (MM)","volume":"17","author":"Cesarman-Maus","year":"2012","journal-title":"Hematology"},{"key":"R16-2-20241211","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/00001721-200204000-00003","article-title":"Activated protein C resistance in the absence of factor V Leiden mutation is a common finding in multiple myeloma and is associated with an increased risk of thrombotic complications","volume":"13","author":"Zangari","year":"2002","journal-title":"Blood Coagul Fibrinolysis"},{"key":"R17-2-20241211","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1055\/s-0037-1615590","article-title":"Hypofi- brinolysis during induction treatment of multiple myeloma may increase the risk of venous thrombosis","volume":"94","author":"van Marion","year":"2005","journal-title":"Thromb Haemost"},{"key":"R18-2-20241211","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1097\/MBC.0b013e3281067fb2","article-title":"Effect on survival of treatment-associated venous thromboembolism in newly diagnosed multiple myeloma patients","volume":"18","author":"Zangari","year":"2007","journal-title":"Blood Coagul Fibrinolysis"},{"key":"R19-2-20241211","doi-asserted-by":"crossref","first-page":"3582","DOI":"10.1182\/blood-2008-04-151076","article-title":"Deep vein thrombosis after monoclonal gammopathy of undetermined significance and multiple myeloma","volume":"112","author":"Kristinsson","year":"2008","journal-title":"Blood"},{"key":"R20-2-20241211","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/0002-9343(85)90540-6","article-title":"Evaluation of hyperviscosity in monoclonal gammopathies","volume":"79","author":"Crawford","year":"1985","journal-title":"Am J Med"},{"key":"R21-2-20241211","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1111\/bjh.14743","article-title":"Serum IgM level as predictor of symptomatic hyperviscosity in patients with Waldenstr\u00f6m macroglobulinaemia","volume":"177","author":"Gustine","year":"2017","journal-title":"Br J Haematol"},{"key":"R22-2-20241211","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1046\/j.1365-2141.2001.03144.x","article-title":"Waldenstr\u00f6m macroglobulinaemia: presenting features and outcome in a series with 217 cases","volume":"115","author":"Garc\u00eda-Sanz","year":"2001","journal-title":"Br J Haematol"},{"key":"R23-2-20241211","doi-asserted-by":"crossref","first-page":"2667","DOI":"10.1002\/cncr.20652","article-title":"Incidence of multiple myeloma in Olmsted County, Minnesota: trend over 6 decades","volume":"101","author":"Kyle","year":"2004","journal-title":"Cancer"},{"key":"R24-2-20241211","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1002\/(SICI)1097-0142(19980315)82:6<1078::AID-CNCR10>3.0.CO;2-3","article-title":"Waldenstr\u00f6m\u2019s macroglobulinemia: incidence patterns in the United States, 1988-1994","volume":"82","author":"Groves","year":"1998","journal-title":"Cancer"},{"key":"R25-2-20241211","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/0090-4295(78)90334-5","article-title":"Priapism and multiple myeloma: successful treatment with plasmapheresis","volume":"12","author":"Rosenbaum","year":"1978","journal-title":"Urology"},{"key":"R26-2-20241211","first-page":"209","article-title":"Priapism in myeloma","volume":"9","author":"Flanagan","year":"1987","journal-title":"Clin Lab Haematol"},{"key":"R27-2-20241211","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/BF03325247","article-title":"A rare but significant cause of priapism in the elderly: multiple myeloma","volume":"23","author":"Bahat","year":"2011","journal-title":"Aging Clin Exp Res"},{"key":"R28-2-20241211","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s12288-016-0722-7","article-title":"Priapism as the presenting manifestation of multiple myeloma","volume":"33","author":"Sahu","year":"2017","journal-title":"Indian J Hematology Blood Transfus"},{"key":"R29-2-20241211","doi-asserted-by":"crossref","first-page":"251","DOI":"10.4103\/iju.IJU_41_17","article-title":"Priapism with penile gangrene: an unusual presentation of multiple myeloma","volume":"33","author":"Panwar","year":"2017","journal-title":"Ind J Urol"},{"key":"R30-2-20241211","doi-asserted-by":"crossref","first-page":"222","DOI":"10.4103\/UA.UA_140_18","article-title":"Malignant refractory priapism: an urologist\u2019 s nightmare","volume":"11","author":"Prabhuswamy","year":"2019","journal-title":"Urol Ann"},{"key":"R31-2-20241211","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.3109\/10428194.2012.656636","article-title":"Priapism as an initial presentation of chronic lymphocytic leukemia","volume":"53","author":"Gogia","year":"2012","journal-title":"Leuk Lymphoma"},{"key":"R32-2-20241211","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1177\/2051415817720355","article-title":"Priapism: a rare initial presentation for chronic lymphocytic leukaemia","volume":"11","author":"Johnson","year":"2018","journal-title":"J Clin Urol"},{"key":"R33-2-20241211","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.3892\/ol.2014.2488","article-title":"Priapism as the initial symptom of primary penile lymphoma: a case report","volume":"8","author":"Gong","year":"2014","journal-title":"Oncol Lett"},{"key":"R34-2-20241211","doi-asserted-by":"crossref","first-page":"e288","DOI":"10.1200\/JCO.2012.46.6003","article-title":"Management of an unusual case of intravascular large B-cell lymphoma of the penis, prostate, and bones with CNS relapse","volume":"31","author":"Wakim","year":"2013","journal-title":"J Clin Oncol"},{"key":"R35-2-20241211","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s10147-011-0273-8","article-title":"Successful treatment of primary malignant lymphoma of the penis by organ-preserving rituximab-containing chemotherapy","volume":"17","author":"Hamamoto","year":"2012","journal-title":"Int J Clin Oncol"},{"key":"R36-2-20241211","doi-asserted-by":"crossref","first-page":"e204","DOI":"10.1097\/RLU.0b013e31823361e1","article-title":"FDG PET\/CT detects malignant lymphoma invading the penis","volume":"36","author":"Guo","year":"2011","journal-title":"Clin Nucl Med"},{"key":"R37-2-20241211","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1002\/ajh.20810","article-title":"Long standing priapism as presentation of lymphoma","volume":"82","author":"Madeb","year":"2007","journal-title":"Am J Hematol"},{"key":"R38-2-20241211","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1001\/jama.1974.03230320013005","article-title":"Priapism in lymphoma","volume":"228","author":"Law","year":"1974","journal-title":"JAMA"},{"key":"R39-2-20241211","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/S0022-5347(17)54472-9","article-title":"Lymphoma of the penis","volume":"126","author":"Gonzalez-Campora","year":"1981","journal-title":"J Urol"},{"key":"R40-2-20241211","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.3892\/ol.2014.2488","article-title":"Priapism as the initial symptom of primary penile lymphoma: a case report","volume":"18","author":"Gong","year":"2014","journal-title":"Oncology letters"}],"container-title":["Hematology\/Oncology and Stem Cell Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1658387621000546?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1658387621000546?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.ovid.com\/10.1016\/j.hemonc.2021.05.003","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T13:40:33Z","timestamp":1787838033000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1016\/j.hemonc.2021.05.003"}},"subtitle":["A Systematic Review"],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":39,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1016\/j.hemonc.2021.05.003","relation":{},"ISSN":["1658-3876"],"issn-type":[{"value":"1658-3876","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]}}}